TY - JOUR T1 - Is there a resistance-threshold for macrolide consumption? Positive evidence from an ecological analysis of resistance data from <em>Streptococcus pneumoniae, Treponema pallidum</em> and <em>Mycoplasma genitalium</em> JF - medRxiv DO - 10.1101/2020.10.13.20212043 SP - 2020.10.13.20212043 AU - Chris Kenyon AU - Sheeba S. Manoharan-Basil AU - Christophe Van Dijck Y1 - 2020/01/01 UR - http://medrxiv.org/content/early/2020/10/14/2020.10.13.20212043.abstract N2 - Background If we were to keep macrolide consumption below a certain threshold, would this reduce the probability of macrolide resistance emerging? No study that we are aware of has addressed this question.Methods We assessed at a country level if there was a macrolide consumption threshold for the selection of a prevalence of macrolide resistance of over 5% in Streptococcus pneumoniae, Treponema pallidum and Mycoplasma genitalium.Results We found evidence for a macrolide consumption threshold of 1.3 defined daily doses per 1000 inhabitants per day (DID) for M. genitalium, 1.8 DID for T. pallidum and 2.3 DID for S. pneumoniae.Conclusions Our results provide further motivation for macrolide stewardship campaigns that strive to reduce macrolide consumption to levels below at least 2 DID.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo funding was received for this studyAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Institute of Tropical Medicine IRBAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data is available as described in the methods section ER -